Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

How Sports Stars and Drugs Keep Getting Reinvented
Reinvention is everywhere. Products get updated, industries change course, and ideas we once treated as finished suddenly come back in a new form. Something that felt permanent five years ago can look completely different today, redesigned for a new audience or a new moment. read more
An Interview With Franco Negron
Simtra’s capability to support high-volume injectables and lower-volume modalities provides balanced expertise across the sterile injectables landscape. read more
The Operational Foundations That Characterize Regulatory Leaders
Holding individuals and teams explicitly accountable for data accuracy and quality might seem straightforward, but it is difficult to sustain in practice. read more
The Next Test for AI in Pharmacovigilance Is Trust, Not Accuracy
An AI model can be right and still not be trusted. That’s what Bristol Myers Squibb (BMS) found six months into rolling out AI-powered adverse event processing: while F1 performance scores were tracking upward, the audit trail found reviewers still reopening cases the system had already cleared. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Kindeva Wins Nerve Agent Autoinjector Contract Worth Up to $226 Million
Tuesday, October 20, 2026
Kindeva’s Meridian Medical Technologies division has received a Defense Logistics Agency contract worth up to $226 million to supply nerve agent ... read more
Recipharm Adds High-Potency Pilot Manufacturing in Spain
Tuesday, October 20, 2026
Recipharm has added pilot-scale manufacturing for high-potency medicines at its Leganés site in Spain, extending the facility’s capabilities from ... read more
AstraZeneca, Oracle Plan AI Collaboration for Clinical Trials
Tuesday, October 20, 2026
AstraZeneca and Oracle Health and Life Sciences have announced a collaboration to test artificial intelligence tools for clinical trial recruitment, ... read more
Fortrea Completes $45 Million Early-Phase Services Acquisition
Tuesday, October 20, 2026
Fortrea has completed its acquisition of Worldwide Clinical Trials’ Early Phase Services division for approximately $45 million in cash, adding ... read more
Genezen, Galibra Partner on SSADH Gene Therapy
Thursday, October 15, 2026
Genezen and Galibra Neuroscience have entered a manufacturing partnership to prepare Galibra’s experimental gene therapy for succinic semialdehyde ... read more